Galapagos NV
GLPG
#4914
Rank
NZ$3.24 B
Marketcap
NZ$48.36
Share price
1.64%
Change (1 day)
6.18%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: NZ$3.24 Billion

As of May 2026 Galapagos NV has a market cap of NZ$3.24 Billion. This makes Galapagos NV the world's 4914th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.24 B-13.58%
2025NZ$3.75 B17.82%
2024NZ$3.18 B-24.69%
2023NZ$4.23 B-7.96%
2022NZ$4.60 B-13.95%
2021NZ$5.34 B-40.4%
2020NZ$8.97 B-55.26%
2019NZ$20.05 B168.08%
2018NZ$7.48 B10.65%
2017NZ$6.76 B57.19%
2016NZ$4.30 B19.44%
2015NZ$3.60 B394.46%
2014NZ$0.72 B-4.5%
2013NZ$0.76 B11.02%
2012NZ$0.68 B50.31%
2011NZ$0.45 B-17.12%
2010NZ$0.55 B57.13%
2009NZ$0.35 B98.18%
2008NZ$0.17 B

End of Day market cap according to different sources

On May 4th, 2026 the market cap of Galapagos NV was reported to be:

NZ$3.18 Billion
by Nasdaq info icon info icon
NZ$3.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$917.05 B 28,136.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$259.09 B 7,877.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$625.62 B 19,163.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$176.47 B 5,333.85%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$474.70 B 14,516.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$483.27 B 14,780.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$173.62 B 5,246.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$0.13 B-95.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$69.94 B 2,053.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel